India is engaging with EU to sort out regulatory issues and strengthen manufacturing practices following the 28-nation block's ban on aroun...

Upcoming Brussels meet between India, EU to look at the ban on around 700 pharma products which were clinically tested by Hyderabad-based G...

Chief negotiators of India and the EU will meet early next year to take the talks further on trade and investment pact BTIA, the Lok Sabha ...

Impetus for FTA with the UK should be given right away during Prime Minister Narendra Modi's ongoing visit to the UK, the industry body sai...

India-EU trade talks, launched way back in June 2007, remain stuck as both sides have major differences on crucial issues including those r...

India is seeking "legal advice" to deal with the recent ban imposed by the European Union on 700 medicines which were clinically tested by ...

Expressing disappointment and concern over the EU ban, India had deferred the talks with the European Union on the proposed free trade agre...

EU defended its decision to ban around 700 generic drugs clinically tested by GVK Biosciences which had prompted India to defer the talks o...

The chief negotiators of India and EU were to meet this month to start the stalled negotiations on the Broadbased Investment and Trade Agre...

India-EU trade talks, which were launched in June 2007, remain stuck as both sides are not satisfied with each other's offers.

Chief negotiators of India and the EU were scheduled to resume the negotiations on the Broadbased Investment and Trade Agreement this month.

EMA's Committee for Medicinal Products for Human Use had looked at over 1,000 pharmaceutical forms and strengths of medicines studied at th...

The German watchdog said it will take a decision shortly on whether to add more medicines to the list of banned drugs in the wake of the EM...

The recommendation is based on findings from an inspection that raised concerns about how GVK conducted studies at the Hyderabad site on be...

Medicines affected by the suspension of marketing authorisation will be allowed to resume sales if the companies furnish fresh clinical tri...

Kantipudi also opined that some of the customers may even ask GVK Bio to pay damages in the event of drug recalls related to the studies co...

European Medicines Agency (EMA) said in a statement that it is reviewing findings of non-compliance with good clinical practise at the GVK ...